Member VoiceDrug Development & Clinical ResearchIndustry TrendsWacker Biotech and Eclipsebio announce strategic collaboration to advance RNA medicine development and productionAugust 4, 2026
AdvocacyCLSPolicy & RegulationA treatment in search of a disease – Legislation unnecessarily threatens California’s leadership in life sciencesJuly 27, 2026The success and productivity of California’s life sciences ecosystem rely on its unique, interconnected structure.
Member VoiceBusiness Operations & InfrastructureResearch & IPGO-Biz Announces Healthcare Trade Mission to South KoreaJuly 23, 2026GO-Biz invites California healthcare companies to join their 2027 California Healthcare Trade Mission to South Korea.
Member VoiceBusiness Operations & InfrastructureResearch & IPGO-Biz Announces Comprehensive South Korea Export Training ProgramJuly 23, 2026GO-Biz invites California-based healthcare companies to apply for an exclusive, comprehensive export training program.
Member VoiceAI & Digital HealthNucleus Biologics Launches CRAIC™ Formulation Finder, Bringing Conversational AI to Cell Culture Media and Buffer DevelopmentJuly 13, 2026Nucleus Biologics, the leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, announced the launch of...
Member VoiceBusiness Operations & InfrastructureApplications Now Open for MBC BioLabs Winter Life Science Vendor ShowcaseJuly 8, 2026
Member VoiceBusiness Operations & InfrastructureResearch & IPLargest law firm merger in history creates Hogan Lovells CadwaladerJuly 1, 2026From Day One, firm delivers unparalleled practice, sector, and regional strength across key G20 markets as clients face increasing global...
Member VoiceResearch & IPProBio’s AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class pan-cancer CAR‑T ProgramJuly 1, 2026The University of California, Irvine (UC Irvine) School of Medicine and GlyTR Therapeutics have developed a next‑generation AAV‑mediated CAR T‑cell...
AdvocacyCLSIndustryIndustry TrendsLab Operations & CostPolicy & RegulationAt BIO 2026, industry wrestled with Washington politics, and making AI work betterJune 25, 2026Executives talked about strategies to adapt to Trump’s way of governance, and the rising cost of AI